Cargando…
Differential Response to α-Oxoaldehydes in Tamoxifen Resistant MCF-7 Breast Cancer Cells
Tamoxifen is the standard adjuvant endocrine therapy for estrogen-receptor positive premenopausal breast cancer patients. However, tamoxifen resistance is frequently observed under therapy. A tamoxifen resistant cell line has been generated from the estrogen receptor positive mamma carcinoma cell li...
Autores principales: | Nass, Norbert, Brömme, Hans-Jürgen, Hartig, Roland, Korkmaz, Sevil, Sel, Saadettin, Hirche, Frank, Ward, Aoife, Simm, Andreas, Wiemann, Stefan, Lykkesfeldt, Anne E., Roessner, Albert, Kalinski, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077828/ https://www.ncbi.nlm.nih.gov/pubmed/24983248 http://dx.doi.org/10.1371/journal.pone.0101473 |
Ejemplares similares
-
Curcumin Blocks Interleukin-1 Signaling in Chondrosarcoma Cells
por: Kalinski, Thomas, et al.
Publicado: (2014) -
Correction: Differential Response to α-Oxoaldehydes in Tamoxifen Resistant MCF-7 Breast Cancer Cells
Publicado: (2014) -
The tamoxifen-regulated, long non-coding RNA LINC00992 affects proliferation, migration, and expression of tamoxifen resistance-associated genes in MCF-7 breast cancer cells
por: Graf, Sebastian, et al.
Publicado: (2022) -
BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study
por: Czapiewski, Piotr, et al.
Publicado: (2022) -
Relationship of micro-RNA, mRNA and eIF Expression in Tamoxifen-Adapted MCF-7 Breast Cancer Cells: Impact of miR-1972 on Gene Expression, Proliferation and Migration
por: Behringer, Akhil, et al.
Publicado: (2022)